Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma
D’Agostino, Mattia, Bertuglia, Giuseppe, Rota-Scalabrini, Delia, Belotti, Angelo, Morè, Sonia, Corradini, Paolo, Oliva, Stefania, Ledda, Antonio, Grasso, Mariella, Pavone, Vincenzo, Ronconi, Sonia, Vincelli, Iolanda Donatella, Ballanti, Stelvio, Velluti, Cristina, Cellini, Claudia, Gozzetti, Alessandro, Palmas, Angelo D., Gamberi, Barbara, Mancuso, Katia, Paris, Laura, Zambello, Renato, Petrucci, Maria Teresa, Bruno, Benedetto, Musto, Pellegrino, Gay, Francesca
Published in Blood (15.02.2024)
Published in Blood (15.02.2024)
Get full text
Journal Article
OAB-011: Predictors of unsustained negativity in minimal residual disease (MRD)-negative transplant-eligible newly diagnosed multiple myeloma (MM) patients enrolled in the FORTE trial
D’Agostino, Mattia, Oliva, Stefania, Rota-Scalabrini, Delia, Petrucci, Maria Teresa, Zambello, Renato, De Sabbata, Giovanni, Liberati, Anna Marina, Pietrantuono, Giuseppe, Tosi, Patrizia, Pisani, Francesco, Capra, Andrea, Velluti, Cristina, Galieni, Piero, Annibali, Ombretta, Monaco, Federico, Pascarella, Anna, Palmieri, Salvatore, Luppi, Mario, Cavo, Michele, Paris, Laura, Bruno, Benedetto, Musto, Pellegrino, Boccadoro, Mario, Gay, Francesca
Published in Clinical lymphoma, myeloma and leukemia (01.08.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.08.2022)
Get full text
Journal Article
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing
Oliva, Stefania, Genuardi, Elisa, Paris, Laura, D'Agostino, Mattia, Rogers, Jennifer, Rota-Scalabrini, Delia, Jacob, Allison P., Patriarca, Francesca, Luppi, Mario, Bertazzoni, Paola, Velluti, Cristina, Capra, Andrea, Saraci, Elona, Rossi, Marco, Allegra, Alessandro, Mina, Roberto, Gentile, Massimo, Kirsch, Ilan R., Belotti, Angelo, Cavo, Michele, Bruno, Benedetto, Musto, Pellegrino, Boccadoro, Mario, Zamagni, Elena, Gay, Francesca
Published in EClinicalMedicine (01.06.2023)
Published in EClinicalMedicine (01.06.2023)
Get full text
Journal Article
OAB-004: Carfilzomib-based induction/consolidation with or without autologous transplant and Lenalidomide (R) or Carfilzomib-Lenalidomide (KR) maintenance: efficacy in high-risk patients of the FORTE study
Mina, Roberto, Zamagni, Elena, Rota-Scalabrini, Delia, Corradini, Paolo, Grasso, Mariella, Ballanti, Stelvio, Giuliani, Nicola, Rosa, Luca De, Cellini, Claudia, Vincelli, Iolanda Donatella, Velluti, Cristina, Capra, Andrea, Cafro, Anna Maria, Gozzetti, Alessandro, Gentile, Massimo, Aquino, Sara, Palmas, Angelo, Ledda, Antonio, Petrucci, Maria Teresa, Musto, Pellegrino, Boccadoro, Mario, Gay, Francesca
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Get full text
Journal Article